Positron (OTCMKTS:POSC – Get Free Report) announced its earnings results on Friday. The company reported ($0.03) earnings per share for the quarter, Zacks reports. The firm had revenue of $0.10 million during the quarter. Positron had a negative net margin of 2,279.55% and a negative return on equity of 2,415.88%.
Positron Price Performance
Shares of OTCMKTS:POSC traded down $0.05 during trading hours on Friday, hitting $1.64. 9,943 shares of the company’s stock traded hands, compared to its average volume of 8,859. Positron has a 1 year low of $1.27 and a 1 year high of $2.74. The business has a fifty day moving average price of $1.73 and a 200-day moving average price of $1.82. The firm has a market capitalization of $54.28 million, a P/E ratio of -5.12 and a beta of 0.67.
Positron Company Profile
Positron Corporation is a medical technology company focused on nuclear medicine and molecular imaging, with an emphasis on cardiac imaging. Its business centers on PET systems and related products and services used by healthcare providers in diagnostic imaging. The company’s product portfolio has included the Attrius PET scanner, a system designed specifically for cardiac applications. Cardiac PET imaging can help clinicians assess heart function and identify coronary artery disease. Positron serves the medical imaging market and has focused on expanding the use of PET technology in cardiology.
Read More
- Five stocks we like better than Positron
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Positron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Positron and related companies with MarketBeat.com's FREE daily email newsletter.
